STERIS plc (NYSE:STE) Shares Purchased by Lbp Am Sa

LBP AM SA boosted its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 151.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,519 shares of the medical equipment provider's stock after buying an additional 15,965 shares during the quarter. LBP AM SA's holdings in STERIS were worth $5,451,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. EverSource Wealth Advisors LLC grew its holdings in STERIS by 41.9% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,117 shares of the medical equipment provider's stock worth $230,000 after purchasing an additional 330 shares during the last quarter. Natural Investments LLC acquired a new stake in shares of STERIS during the fourth quarter worth $334,000. Citizens Financial Group Inc. RI lifted its stake in shares of STERIS by 5.9% during the fourth quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider's stock worth $201,000 after buying an additional 54 shares during the period. Daiwa Securities Group Inc. lifted its stake in shares of STERIS by 6.6% during the fourth quarter. Daiwa Securities Group Inc. now owns 14,632 shares of the medical equipment provider's stock worth $3,008,000 after buying an additional 908 shares during the period. Finally, Amundi lifted its stake in shares of STERIS by 28.1% during the fourth quarter. Amundi now owns 459,066 shares of the medical equipment provider's stock worth $96,142,000 after buying an additional 100,740 shares during the period. 94.69% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

STERIS Stock Performance

NYSE STE traded down $2.89 on Wednesday, reaching $225.44. 450,628 shares of the company's stock traded hands, compared to its average volume of 500,678. The firm has a market cap of $22.15 billion, a price-to-earnings ratio of 47.86 and a beta of 0.92. The stock has a 50 day moving average price of $220.09 and a 200-day moving average price of $222.22. STERIS plc has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities research analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be paid a dividend of $0.57 per share. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a yield of 1.01%. STERIS's dividend payout ratio is presently 48.41%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Stephens reiterated an "overweight" rating and set a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. JMP Securities reiterated a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Finally, Piper Sandler boosted their target price on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $258.75.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.